Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 167   

Articles published

GSK 1,541.50 +7.00 (0.46%)
price chart
Are Genus plc And Dechra Pharmaceuticals plc Better Buys Than ...
While shares in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) have disappointed in the last year, it has not been the same story for a number of its pharmaceutical rivals.
Credit Suisse Group AG Reaffirms Underperform Rating for GlaxoSmithKline plc ...
GlaxoSmithKline plc logo Credit Suisse Group AG reaffirmed their underperform rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a research note issued to investors on Friday. Credit Suisse Group AG has also updated their ratings on a number of ...
Jefferies Group Reiterates "Hold" Rating for GlaxoSmithKline plc (GSK)  The Legacy
According To This Fund Manager, GlaxoSmithKline plc Is A Tremendous ...
GlaxoSmithKline's (LSE: GSK) shares are a tremendous opportunity for income investors, according to Adrian Frost, manager of the �7.3 billion Artemis Income fund.
Why I'd Buy Tesco PLC, Hold GlaxoSmithKline plc & Dump Diageo PLC
Three stocks with three different risk profiles: Tesco (LSE: TSCO), GlaxoSmithKline (LSE: GSK) and Diageo (LSE: DGE).
5 Reasons Why Dividends Are Back: BHP Billiton plc, BP plc, GlaxoSmithKline ...
Dividends are back, with 2015 set to see the strongest underlying growth in three years at 6.4%, according to new research from Capita Asset Services.
3 Of The Best Pharmaceutical Stocks That Money Can Buy: GlaxoSmithKline plc ...
When top and bottom line growth are proving elusive for any company, a period of rationalisation and restructuring often follows. That's the current situation at GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US), where sales and profit growth have stalled in ...
5 Growth Greats You Simply Can't Ignore: GlaxoSmithKline plc, British American ...
The enduring effect of patent losses across key drugs is expected to keep earnings on the back foot at GlaxoSmithKline (LSE: GSK) for a little while longer. Indeed, the business is expected to clock up its fourth consecutive annual bottom line decline ...
Why Is Neil Woodford So Confident About GlaxoSmithKline plc?  Yahoo Finance UK
GlaxoSmithKline plc vs Shire PLC: Which Pharma Stock Is The Better Buy?
2015 is forecast to be a challenging year for both GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and Shire (LSE: SHP) (NASDAQ: SHPG.
3 Great Growth Stocks For Savvy Investors: GlaxoSmithKline plc, Legal ...
Considering that GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has been steadily battered by a stream of patent expirations across key products, at first glance the pharma play not be an obvious pick for those seeking reliable earnings growth.
My Perfect 2015 ISA: National Grid plc, Lloyds Banking Group PLC ...
One of the two big pharmaceuticals must be in my portfolio too, and there's little to choose between GlaxoSmithKline (LSE: GSK) and AstraZeneca. But it's Glaxo that gets my nod, because I think it's a little out of the spotlight at the moment. Though ...